To further evaluate the selectivity and anticancer efficacy of AC0010, we used NCI-H1975 (EGFR L858R/T790M NSCLC cells), A549 (wild-type EGFR NSCLC cells), and HFF-1 (fibroblasts) cells. This evidence concerns the gene EGFR and non-small cell lung carcinoma.